PreciseDx: Valuation, Funding & Investors
PreciseDx is a leading innovator in oncology diagnostics that utilizes Artificial Intelligence (AI) for morphology-driven disease analysis. The company focuses on developing advanced diagnostic tools, such as PreciseBreast™, to enhance risk assessment and improve clinical outcomes in oncology.
Leadership & Board
- Current Number of Employees
- 28
- Current LinkedIn Followers
- 2,253
Latest Estimated Valuation
- Total Amount Raised
- $21M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $21M
- Latest Funding Round
- Series B
Employee Trend
PreciseDx had 28 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
28Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
PreciseDx had 2,253 followers as of November 2, 2026. The number of followers increased by 11 (0.49%) week-over-week.
2,253Latest Followers Count
11(0.49%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Series B | $20.70M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Eventide Asset Management | Series B |
Similar Companies
A snapshot of private companies similar to PreciseDx, helping you discover and navigate related company profiles.
Related News and Analysis
